.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
US Army
Accenture
Merck
Colorcon
Covington
Baxter
Chinese Patent Office
Queensland Health
Julphar

Generated: December 12, 2017

DrugPatentWatch Database Preview

Gemfibrozil - Generic Drug Details

« Back to Dashboard

What are the generic sources for gemfibrozil and what is the scope of gemfibrozil freedom to operate?

Gemfibrozil
is the generic ingredient in two branded drugs marketed by Mylan, Purepac Pharm, Pfizer Pharms, Apotex, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Caribe Holdings, Chartwell Molecules, Hikma Pharms, Impax Pharms, Invagen Pharms, Northstar Hlthcare, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

Fifty-one suppliers are listed for this compound. There is one tentative approval for this compound.

Medical Subject Heading (MeSH) Categories for gemfibrozil

Tentative approvals for GEMFIBROZIL

Applicant Application No. Strength Dosage Form
u► Subscribe300MGCAPSULE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LtdGEMFIBROZILgemfibrozilTABLET;ORAL202726-001Sep 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Purepac PharmGEMFIBROZILgemfibrozilCAPSULE;ORAL072929-001Jan 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell MoleculesGEMFIBROZILgemfibrozilTABLET;ORAL074270-001Sep 27, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer PharmsLOPIDgemfibrozilCAPSULE;ORAL018422-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanGEMFIBROZILgemfibrozilTABLET;ORAL074452-001Feb 16, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsGEMFIBROZILgemfibrozilTABLET;ORAL077836-001Jul 27, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozGEMFIBROZILgemfibrozilTABLET;ORAL074615-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanGEMFIBROZILgemfibrozilCAPSULE;ORAL073466-001Jan 25, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer PharmsLOPIDgemfibrozilTABLET;ORAL018422-003Nov 20, 1986ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Northstar HlthcareGEMFIBROZILgemfibrozilTABLET;ORAL079072-001Sep 13, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: gemfibrozil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PharmsLOPIDgemfibrozilCAPSULE;ORAL018422-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer PharmsLOPIDgemfibrozilCAPSULE;ORAL018422-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Chubb
Cantor Fitzgerald
Fuji
Deloitte
Cerilliant
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot